WesMark Balanced holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
WesMark Balanced Fund WMBLX
- NAV / 1-Day Return 14.61 / +0.55 %
- Total Assets 103.2M
-
Adj. Expense Ratio
1.290%
- Expense Ratio 1.290%
- Distribution Fee Level High
- Share Class Type No Load
- Category Moderate Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity —
- Status Open
- TTM Yield 1.52%
- Turnover 22%
USD | NAV as of Jun 16, 2026 | 1-Day Return as of Jun 16, 2026, 12:42 AM GMT+0
Morningstar’s Analysis WMBLX
Will WMBLX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the WMBLX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of WMBLX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Apple Inc | 4.80 | 5M | Technology |
Federated Hermes Govt Obl Premier | 3.15 | 3M | Cash and Equivalents |
Microsoft Corp | 2.85 | 3M | Technology |
Chevron Corp | 2.82 | 3M | Energy |
Caterpillar Inc | 2.68 | 3M | Industrials |
JPMorgan Chase & Co | 2.65 | 3M | Financial Services |
Alphabet Inc Class A | 2.47 | 2M | Communication Services |
Cisco Systems Inc | 2.29 | 2M | Technology |
AbbVie Inc | 2.29 | 2M | Healthcare |
Merck & Co Inc | 2.24 | 2M | Healthcare |
United States